Rapid Oxygen
Rapid Oxygen: Medtech firm offering FDA-cleared, portable, non-explosive oxygen devices for emergencies.
Founded
2016Rapid Oxygen: Medtech firm offering FDA-cleared, portable, non-explosive oxygen devices for emergencies.
Founded with the mission to make emergency oxygen accessible and safe for everyone, Rapid Oxygen is a medtech company that produces the R15, a patented portable oxygen device. Designed in collaboration with the University of Michigan, the R15 provides 100% oxygen for airway and cardiac emergencies and can be operated by any Good Samaritan without prior training or certification. The device is non-explosive and portable, making it permissible in public areas where traditional oxygen cylinders are restricted by law. The R15 is FDA-cleared, ensuring its reliability and safety in critical situations.
Rapid Oxygen has garnered attention from notable investors and medical professionals who recognize the life-saving potential of its technology. The company's key achievements include FDA clearance for the R15 and successful market penetration in both public and private sectors. By providing a reliable, easy-to-use oxygen solution, Rapid Oxygen has significantly impacted emergency medical response, potentially saving countless lives by making oxygen readily available in situations where every second counts.
Companies similar to Rapid Oxygen include Aeronics, Respirogen, Raydiant Oximetry and Inogen.
Rapid Oxygen was founded in 2016.
Rapid Oxygen's headquarters is located in Stamford, CT, US.
Rapid Oxygen's most recent funding round was for $3.5M (USD) in June 2018.
As of Jun 14, 2018, Rapid Oxygen has disclosed funding of $5.5M (USD). Undisclosed round amounts are excluded.
Rapid Oxygen has 75 employees as of Feb 5, 2024.
Inogen
